Article Per Year (5 Year)
p-Index From 2020 - 2025
2.56
P-Index
This Author published in this journals
All Journal Jurnal Farmasi Klinik Indonesia Acta Pharmaceutica Indonesia Journal of Islamic Pharmacy Jurnal Farmasi Galenika (Galenika Journal of Pharmacy) As-syifaa Jurnal Farmasi Acta Pharmaciae Indonesia : Acta Pharm Indo Adi Widya : Jurnal Pengabdian Masyarakat Majalah Farmaseutik Media Ilmu Kesehatan Pharmacology and Clinical Pharmacy Research Journal of Nursing and Public Health (JNPH) Herbal Medicine Journal
amelia rumi, amelia
Unknown Affiliation
Biochemistry, Genetics & Molecular Biology Chemistry Health Professions Immunology & microbiology Medicine & Pharmacology Nursing Public Health Social Sciences Other

Published : 15 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 15 Documents
Search

 1   2 
Edukasi dan Skrining Kasus Diabetes pada Pelajar di SMA Negeri 1 Palu Afriani Kusumawati; Rumi, Amelia; Rudi Safaruddin; Arya Dibyo Adisaputra
Adi Widya : Jurnal Pengabdian Masyarakat Vol 9 No 1 (2025): Adi Widya: Jurnal Pengabdian Masyarakat
Publisher : Lembaga Penelitian dan Pengabdian Masyarakat

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33061/awpm.v9i1.11992

Abstract

Diabetes is a chronic disease that makes the body lose its ability to produce insulin or begin to use it less efficiently leading to high blood sugar. Without proper treatment, over time, this disease can lead to more serious health problems such as heart disease, vision loss, and kidney disease. Early detection and prevention are crucial in mitigating these risks. This study focuses on conducting an early screening for diabetes among high school students at SMA Negeri 1 Palu. Additionally, this activity aims to educate students at SMA Negeri 1 Palu on the importance of maintaining a healthy lifestyle by managing their sugar intake according to daily caloric needs. The program utilized an interactive educational approach, incorporating demonstration tools and discussions to enhance engagement and understanding. A total of 68 students participated in this initiative which was evaluated through a final assessment measuring knowledge improvement and awareness of diabetes prevention.
Evaluasi Kadar Glukosa Darah Pada Pasien Hipertensi yang Menggunakan Obat Golongan Angiostensin Receptor Bloker (ARB) di Rumah Sakit Umum Daerah Undata Palu Susilawati, Ni Made; Fresha, Winda; Rumi, Amelia; Adisaputra, Arya Dibyo
Herbal Medicine Journal Vol 8 No 1 (2025): Herbal Medicine Journal
Publisher : Program Studi S1 Farmasi, STIKES Senior, Medan

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.58996/hmj.v8i1.151

Abstract

Hipertensi adalah kondisi medis yang ditandai dengan peningkatan tekanan darah arteri secara berkelanjutan. Salah satu golongan obat lini pertama pengobatan hipertensi adalah golongan Angiotensin Receptor Blocker (ARB). Obat ini berpotensi dapat dapat mempengaruhi metabolisme glukosa darah. Penelitian ini bertujuan untuk mengevaluasi kadar glukosa darah pada pasien hipertensi yang menjalani terapi menggunakan obat ARB, seperti losartan, candesartan, valsartan, dan telmisartan, di RSUD Undata Palu. Penelitian ini dilakukan dengan metode cross-sectional secara prospektif, melibatkan 30 pasien yang memenuhi kriteria inklusi. Pasien yang diteliti berusia ≥18 tahun, telah menjalani terapi ARB selama 3 bulan, memiliki hipertensi tanpa diabetes melitus, dan tidak menggunakan obat lain yang memengaruhi kadar glukosa darah. Pengukuran dilakukan menggunakan glucometer Accu-Chek Performa. Hasilnya menunjukkan penurunan kadar glukosa darah puasa dari rata-rata 113.83 mg/dl menjadi 107.83 mg/dl, dengan selisih 6.367 mg/dl. Uji statistik menunjukkan p=0.049 (p<0.05), yang mengindikasikan bahwa ARB dapat menurunkan kadar glukosa darah pada pasien hipertensi.
ANALISIS FAKTOR TINGKAT KEPATUHAN PENGOBATAN PASIEN DIABETES MELITUS DI PUSKESMAS BIROBULI PALU HARDANI, RIRIEN; RUMI, AMELIA; AURELIA, DIVA
Journal of Nursing and Public Health Vol 13 No 1 (2025)
Publisher : UNIVED Press, Universitas Dehasen Bengkulu

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37676/jnph.v13i1.8515

Abstract

Pendahuluan: Peningkatan prevalensi diabetes melitus (DM) setiap tahunnya menjadi salah satu permasalahan dalam dunia medis, salah satu penyebab rendahnya keberhasilan terapi adalah tingkat kepatuhan pengobatan yang rendah. Tujuan dari penelitian ini yaitu untuk mengetahui profil pengobatan, tingkat kepatuhan, serta faktor yang mempengaruhi tingkat kepatuhan pengobatan pasien DM di Puskesmas Birobuli Palu. Metode: Penelitian ini dilakukan secara cross-sectional menggunakan kuesioner MMAS-8 (8-item Morisky Medication Adherence Scale) dimana data yang diperoleh dianalisis menggunakan uji Chi-square dan regresi statistik. Hasil dan Pembahasan: Penggunaan antidiabetes terbanyak adalah melalui terapi oral (80,38%) dengan tingkat kepatuhan pasien tinggi (66,46%). Faktor yang mempengaruhi tingkat kepatuhan pasien adalah tingkat pendidikan (p=0,045), frekuensi pengobatan (p=0,019) dan jumlah obat DM (p=0,000). Analisis multivariat menunjukkan tingkat pendidikan (P=0,013) dan jumlah obat DM (P=0,000) memiliki hubungan yang kuat terhadap kepatuhan pasien. Kesimpulan: Pasien DM di Puskesmas Birobuli mayoritas menggunakan antidiabetes oral dan memiliki tingkat kepatuhan yang tinggi, serta faktor yang berhubungan kuat terhadap kepatuhan pengobatan adalah tingkat pendidikan sedang serta jumlah obat DM yang tunggal.
The Evaluation of Fasting Plasma Glucose (FPG) Levels in Hypertensive Patients Using Calcium Channel Blocker (CCB) Drugs Class in Undata Regional Hospital: Evaluasi Kadar Glukosa Plasma Puasa (GPP) pada Pasien Hipertensi Menggunakan Obat Kelas Pemblok Kanal Kalsium di Rumah Sakit Daerah Undata Rumi, Amelia; Fitriana, Anggun
Jurnal Farmasi Galenika (Galenika Journal of Pharmacy) (e-Journal) Vol. 7 No. 2 (2021): (October 2021)
Publisher : Universitas Tadulako

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22487/j24428744.2021.v7.i2.15463

Abstract

Background: Hypertension plays a major role in the development of heart disease which is one of the most leading causes of death worldwide. Antihypertensives must be selected carefully to avoid affecting metabolic parameters. A risky case involving the increase of plasma glucose levels using Calcium Channel Blocker (CCB) antihypertensive, amlodipine, has been reported. Objectives: This study aims to examine the effects of CCB treatments on blood glucose levels in hypertensive patients at the Undata District General Hospital of Central Sulawesi Province. Material and Methods: This study used a cross-sectional design with a prospective approach. The instruments & materials used in this study are Accu-Chek Performa glucometer along with the patient's blood sample material. The research subjects were 31 patients who met the inclusion criteria; patients had been treated with CCB therapy for 3 months, patients were not diagnosed with diabetes mellitus, andpatients did not use drugs that might affect the blood glucose levels. Results: The results showed an average value of fasting plasma glucose (FPG) levels of hypertension patients using CCB class showed an increase from baseline of 124,619 mg/dL to 141,612 mg/dL with a difference of 16,993 mg/dL. Statistical analysis conducted also obtained a significance value of p 0,000 which indicates that the use of amlodipine can significantly increase fasting patients' plasma glucose levels. Conclusions: If observed clinically, the increasing in fasting plasma glucose values ​​falls into the category of mild to moderate hyperglycemic.
Effect of Metformin Therapy on Low Density Lipoprotein (LDL) Levels in Type 2 Diabetes Mellitus Patients at Undata Hospital in Palu City Central Sulawesi: Efek Terapi Metformin terhadap Level Low Density Lipoprotein (LDL) pada Pasien Diabetes Mellitus Tipe 2 pada RS Undata di Kota Palu Sulawesi Tengah Mukaddas, Alwiyah; Rumi, Amelia; Yulianti, Tri
Jurnal Farmasi Galenika (Galenika Journal of Pharmacy) (e-Journal) Vol. 8 No. 1 (2022): (March 2022)
Publisher : Universitas Tadulako

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22487/j24428744.2022.v8.i1.15596

Abstract

Background: Metformin, which can control blood glucose levels, can reduce LDL levels in type 2 DM patients. Objectives: To determine the mean value of pre and post LDL in type 2 DM patients after receiving metformin therapy for three months. Methods: This study used a cross-sectional study with a prospective approach, It was done by conducting pre and post examination of LDL levels using metformin. This study was analyzed using the SPSS Wilcoxon statistical test. The total sample that met the inclusion and exclusion criteria was 18 respondents. Results: This study used a single metformin value (sig = 0.000 <0.05) with a baseline mean value of 148.22 mg / dL and an evaluation of 133.56 mg / dL where the difference in reduction was 14.66 mg / dL. Conclusion: There was a decrease in LDL levels in type 2 DM patients after using metformin for three months.
Co-Authors A. Khairinisa, Miski Adisaputra, Arya Dibyo Afriani Kusumawati afriani kusumawati, afriani Alwiyah Mukaddas Alydrus, Rugayyah Ambiati, Nurul Andriani, Lilik Arya Dibyo Adisaputra Aulia, Raiza AURELIA, DIVA Budiyanto, Titi Dwi Cahyani Dondokambey, Dessy Natalia firdawati amir parumpu, firdawati amir Fitriana, Anggun Fresha, Winda Hasymi, Abdurrahman Manikam, Nurintan Kurnia Masyita, Andi Athira Masyita, Andi Atirah Muhamad Rinaldhi Tandah Muhammad Faisal Natasya, Putri Ni Made Susilawati Nurul Ambianti Parumpu, Firda Amir Parumpu, Firdawati Purwanti, Rani putri, amanda Ririen Hardani Rosita, Habiba Rudi Safaruddin Sakaria, Hamra Serli, Serli Setiawati Fadhilah Zainal Sri Sulistiana Syarifuddin, Nuryani Tahir, Muhammad Tamrin Tamrin, M. Tri Yulianti, Tri Yusriadi Yusriadi